Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Seventeenth approval for Amphocil/Amphotec

Oct. 25, 1996

Key patents issued covering Applied Microbiology's lanthocins

Oct. 25, 1996

Natural antibacterial chitinase inhibitors

Oct. 25, 1996

New cephalosporin derivatives from Roche

Oct. 25, 1996

Albendazole introduced in the U.S. for two parasitic infections

Oct. 18, 1996

Glaxo Wellcome claims antiviral agents with RNA virus specificity

Oct. 18, 1996

RiboGene receives grant for antiviral compounds based on PKR

Oct. 18, 1996

Antimicrobial collaboration between Human Genome Sciences and Pharmacia & Upjohn

Oct. 18, 1996

Neuprex enters pivotal trials

Oct. 18, 1996

Bristol-Myers Squibb obtains rights to Kyorin antibiotic

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...